Uveitis in juvenile idiopathic arthritis

Area of Science:

• Ophthalmology
• Rheumatology
• Pediatrics

Background:

• Juvenile idiopathic arthritis (JIA) is a leading cause of childhood uveitis, affecting approximately 1 in 10,000 individuals.
• JIA-associated uveitis often presents with severe inflammation, posing a significant risk to vision.

Purpose of the Study:

• To review the current understanding of juvenile idiopathic uveitis diagnosis and treatment.
• To highlight the importance of early detection and comprehensive management strategies for JIA-related uveitis.

Main Methods:

• A selective literature search was conducted up to August 2014.
• The review incorporates findings from pertinent articles and the current interdisciplinary S2k guideline on juvenile idiopathic uveitis.

Main Results:

• Uveitis occurs in about 10% of JIA patients, with girls being more commonly affected (75-80%).
• Early eye examinations are recommended upon JIA diagnosis. Antinuclear antibodies are present in 70-90% of cases.
• Treatment involves topical corticosteroids initially, with systemic immunosuppression or immune modulators used for persistent or severe cases, improving visual outcomes.

Conclusions:

• Multidisciplinary and individualized treatment is essential for managing the chronic nature of JIA-associated uveitis and its complications.
• Severely affected patients benefit from specialized care in competence centers for optimal long-term outcomes.
• Future advancements require population-based registries and basic research into biomarkers for predicting disease course and treatment response.